Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Non-Hodgkin lymphoma risk in adults living with HIV across five continents

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. No evidence of increased risk of thyroid dysfunction in well-treated people living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Shared heritability and functional enrichment across six solid cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: The relative impact of immune deficiency and lifestyle-related factors on risk of cancer in the HIV-infected population is controversial. We aimed to estimate the population-attributable fractions (PAFs) associated with smoking, being HIV-infected and with immune deficiency.

METHODS: In a Danish, nationwide, population-based cohort study (1995-2011), incidences of cancer were compared between an HIV-infected cohort and a population-based matched cohort in analyses stratified on cancer category, smoking status and for HIV patients: low CD4 cell count.

RESULTS: We included 3503 HIV patients [baseline CD4 450 cells/μl (inter-quartile range 310-630)] and 12 979 population controls. Smoking-related and virological cancers accounted for 23 and 43% of cancers in the HIV-infected population. The risk of these cancers were higher among HIV patients compared to controls [incidence rate ratio (IRR) 2.8, 95% confidence interval (CI) 1.6-4.9; and IRR 11.5, 95% CI 6.5-20.5], whereas the risk of other cancers did not differ (IRR 1.0, 95% CI 0.7-1.3). Non-smoking HIV patients did not have increased risk of non-virological cancers compared to non-smoking controls (IRR 1.2, 95% CI 0.7-2.1). The PAFs of cancer associated with smoking and with being HIV-infected were 27 and 49%, respectively. For cancers not strongly related to smoking or viral infections, the PAFs associated with being HIV-infected and with immune deficiency were 0%.

CONCLUSION: The risk of cancer is increased in HIV patients compared to the background population. In absence of smoking, the increase in risk is confined to cancers related to viral infections, whereas the risk of other cancers is not elevated and does not seem to be associated with immune deficiency.

Original languageEnglish
JournalAIDS (London, England)
Volume28
Issue number10
Pages (from-to)1499-508
Number of pages10
ISSN0269-9370
DOIs
Publication statusPublished - 19 Jun 2014

ID: 44360900